---
title: "Wolwo Pharma: Application for clinical trial of dermatitis diagnostic patch 02 has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230459435.md"
description: "According to the Zhitong Finance APP, Wolwo Pharma announced that the company has received the \"Acceptance Notice\" issued by the National Medical Products Administration, and the clinical trial application for the \"Dermatitis Diagnostic Patch 02\" submitted by the company has been officially accepted. The relevant indications are: for patch testing, to assist in the diagnosis of allergic contact dermatitis related to sensitization by carbamates, p-phenylenediamine, and formaldehyde"
datetime: "2025-03-04T09:44:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230459435.md)
  - [en](https://longbridge.com/en/news/230459435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230459435.md)
generator: "portal-rs"
---

# Wolwo Pharma: Application for clinical trial of dermatitis diagnostic patch 02 has been accepted

According to the Zhitong Finance APP, Wolwo Pharma (300357.SZ) announced that the company has received the "Acceptance Notice" issued by the National Medical Products Administration, and the clinical trial application for the "Dermatitis Diagnostic Patch 02" submitted by the company has been officially accepted. The relevant indications are: for patch testing, to assist in the diagnosis of allergic contact dermatitis related to sensitization by carbamates, p-phenylenediamine, and formaldehyde

### Related Stocks

- [300357.CN](https://longbridge.com/en/quote/300357.CN.md)

## Related News & Research

- [AI isn’t close to curing cancer. This startup says it knows what it will take.](https://longbridge.com/en/news/296352961.md)
- [BioArctic, Mesenkia partner to develop BrainTransporter-enabled antibody for glioblastoma](https://longbridge.com/en/news/296330014.md)
- [BioArctic and Mesenkia enter oncology research collaboration](https://longbridge.com/en/news/296333958.md)
- [Turn Therapeutics says mouse study shows GX-03 cuts dermatitis severity 66%](https://longbridge.com/en/news/296487429.md)
- [Is Royalty Pharma (RPRX) Undervalued On Its $100 Million Zealand Pharma Royalty Deal?](https://longbridge.com/en/news/296647266.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**